✦ LIBER ✦

PTEN Mutations in Malignant Gliomas and their Relation with Meningeal Gliomatosis

✍ Scribed by S. Izumoto; T. Ohnishi; H. Kanemura; N. Arita; M. Maruno; S. Moriuchi; T. Suzuki; T. Yoshimine

Book ID: 110304618
Publisher: Springer US
Year: 2001
Tongue: English
Weight: 198 KB
Volume: 53
Category: Article
ISSN: 0167-594X
DOI: 10.1023/a:1011839920176

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PTEN/MMAC1 mutations in primary glioblas

PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas

✍ Chiariello, Elena; Roz, Luca; Albarosa, Ruth; Magnani, Ivana; Finocchiaro, Gaeta 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 314 KB

Combination gene therapy with PTEN and E

Combination gene therapy with PTEN and EGFR siRNA suppresses U251 malignant glioma cell growth in vitro and in vivo

✍ Lei Han; An-ling Zhang; Peng Xu; Xiao Yue; Yang Yang; Guang-xiu Wang; Zhi-fan Ji 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 832 KB

Detection of FLT3/ITD gene mutations in

Detection of FLT3/ITD gene mutations in patients with hematologic malignancy and their clinical significance

✍ Bing Xu; Guoshu Chen; Xiaodan Luo; Jiahong Tang 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 226 KB

O6-methylguanine-DNA methyltransferase m

O6-methylguanine-DNA methyltransferase methylation and TP53 mutation in malignant astrocytomas and their relationships with clinical course

✍ Takao Watanabe; Yoichi Katayama; Chiaki Komine; Atsuo Yoshino; Akiyoshi Ogino; T 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 111 KB

Epigenetic silencing of O 6 -methylguanine-DNA methyltransferase (MGMT) by promoter methylation can confer cancer cells with an increased sensitivity to alkylating chemotherapeutic agents and a higher susceptibility to TP53 transition mutations. The aim of our study was to assess the correlation of

RAS, FLT3, and TP53 mutations in therapy

RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7

✍ Lucy E. Side; Nicole P. Curtiss; Kathryn Teel; Christian Kratz; Pauline W. Wang; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

## Abstract Oncogenic mutations in the __KRAS2__, __NRAS__, or __FLT3__ gene are detected in more than 50% of patients with de novo acute myeloid leukemia (AML). __RAS__ mutations are also prevalent in de novo myelodysplastic syndrome (MDS), especially chronic myelomonocytic leukemia and juvenile m

Novel CARD15/NOD2 mutations in Finnish p

Novel CARD15/NOD2 mutations in Finnish patients with Crohn's disease and their relation to phenotypic variation in vitro and in vivo

✍ Maarit Lappalainen; Paulina Paavola-Sakki; Leena Halme; Ulla Turunen; Martti Fär 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

## Background: Three mutations (r702w, g908r, and 1007fs) of the card15/nod2 gene associate with crohn's disease (cd). despite a strong linkage of cd to the inflammatory bowel disease (ibd) 1 region, only 16% of the finnish cd patients carry 1 of these 3 mutations, pointing to the possibility of ye